One giant leap for cephalexin dosing, one small step for antimicrobial stewardship

被引:0
作者
Chin, Paul Ken Leong [1 ,2 ]
Than, Martin [3 ]
Chambers, Stephen [4 ]
机构
[1] Univ Otago, Dept Med, Private Bag, Christchurch 4345, New Zealand
[2] Te Whatu Ora Hlth New Zealand, Dept Clin Pharmacol, Christchurch, Waitaha Canterb, New Zealand
[3] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand
[4] Univ Otago, Dept Pathol, Christchurch, New Zealand
关键词
Cephalexin; Cellulitis; Emergency department; Pharmacokinetics;
D O I
10.1007/s43678-022-00442-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:7 / 8
页数:2
相关论文
共 5 条
  • [1] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
    Craig, WA
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) : 1 - 10
  • [2] Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial
    Dalen, Dawn
    Fry, Amy
    Campbell, Samuel G.
    Eppler, Jeffrey
    Zed, Peter J.
    [J]. EMERGENCY MEDICINE JOURNAL, 2018, 35 (08) : 492 - 498
  • [3] What is antimicrobial stewardship?
    Dyar, O. J.
    Huttner, B.
    Schouten, J.
    Pulcini, C.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (11) : 793 - 798
  • [4] Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers
    Everts, Richard J.
    Gardiner, Sharon J.
    Zhang, Mei
    Begg, Ronald
    Chambers, Stephen T.
    Turnidge, John
    Begg, Evan J.
    [J]. JOURNAL OF INFECTION, 2021, 83 (02) : 182 - 189
  • [5] Yadav, 2022, HIGH DOSE CEPHALEXIN